Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-20

Clinical Trial Update: The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa [NA]

View source ↗

Summary

A completed clinical trial assessing the effect of oral 9-cis rich powder from the alga Dunaliella bardawil on visual function in patients with Retinitis Pigmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dunaliella bardawil 9-cis rich powder (9-cis rich powder of the alga Dunaliella bardawil)

Snippet

Sponsor: Sheba Medical Center | Conditions: Retinitis Pigmentosa | NA | Status: COMPLETED